gene_symbol
MET
hgnc_id
HGNC:7029
binding_type
antigen recognition
cytotoxicity
YES
cytotoxicity_type
DIRECT
cytotoxicity_mechanism
Amivantamab binds MET on target cells and engages Fcγ receptor–bearing immune cells to mediate ADCC/ADCP, directly killing MET-expressing cells (with additional receptor internalization/degradation).
enzyme_product
Off
epitope
Off
variant
Off
isoform
Off
hla_specific
Off
gated
Off
other_modifier
Receptor tyrosine kinase (HGFR/c-Met); blocks ligand binding; induces internalization/degradation; engages Fc-mediated ADCC/ADCP
trial_id_tar_ref
drug_id_tar_ref
disease_id_tar_ref
nct_id_tar_ref
NCT05801029
disease_id_num_tar_ref
6005
drug_id_num_tar_ref
16293